Business Context and Reporting Period
This Form 8-K reports on the 2015 Annual Meeting of Stockholders held by Cara Therapeutics, Inc. on June 8, 2015. The filing details the results of shareholder votes on director elections and the ratification of the independent auditor. Note: The request metadata references "Tvardi Therapeutics, Inc.," but the filing text explicitly identifies the registrant as "Cara Therapeutics, Inc."
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and voting results.
Material Changes and Voting Results
Two proposals were submitted to a vote of security holders:
- Proposal 1: Election of Directors
- Harrison M. Bains, Jr. was elected to the Board of Directors until the 2018 Annual Meeting.
- Votes For: 11,412,603
- Votes Withheld: 84,891
- Broker Non-Votes: 5,087,184
- Proposal 2: Ratification of Independent Auditor
- Stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2015.
- Votes For: 16,278,064
- Votes Against: 300,964
- Votes Abstain: 5,650
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on financial performance, risks, contingencies, or unusual items. It references a Proxy Statement filed on April 24, 2015, for more detailed descriptions of the proposals.
Key Facts for Investor Verification
- Verify the correct registrant name is Cara Therapeutics, Inc., not Tvardi Therapeutics, Inc.
- Confirm the tenure of the newly elected director, Harrison M. Bains, Jr., extends to the 2018 Annual Meeting.
- Note the significant number of broker non-votes (over 5 million) regarding the director election.
- Confirm that Ernst & Young LLP is the appointed auditor for the fiscal year ending December 31, 2015.